Literature DB >> 9709051

Poxvirus dilemmas--monkeypox, smallpox, and biologic terrorism.

J G Breman1, D A Henderson.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9709051     DOI： 10.1056/NEJM199808203390811

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  44 in total

Review 1.  Bioterrorism: implications for the clinical microbiologist.

Authors:  W F Klietmann; K L Ruoff
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Detection of smallpox virus DNA by LightCycler PCR.

Authors:  Mark J Espy; Franklin R Cockerill III; Richard F Meyer; Michael D Bowen; Gregory A Poland; Ted L Hadfield; Thomas F Smith
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  Mysteries of the smallpox vaccine.

Authors:  Sanjoy Bhattacharya
Journal:  J Biosci       Date:  2003-03       Impact factor: 1.826

Review 4.  Recognizing the real threat of biological terror.

Authors:  Richard P Wenzel
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

5.  Smallpox and biological warfare: a disease revisited.

Authors:  Stefan Riedel
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-01

6.  Role for CCR5 in dissemination of vaccinia virus in vivo.

Authors:  Ramtin Rahbar; Thomas T Murooka; Eleanor N Fish
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

7.  Vacated niches, competitive release and the community ecology of pathogen eradication.

Authors:  James O Lloyd-Smith
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

8.  Vaccinia reporter viruses for quantifying viral function at all stages of gene expression.

Authors:  Daniel K Rozelle; Claire Marie Filone; Ken Dower; John H Connor
Journal:  J Vis Exp       Date:  2014-05-15       Impact factor: 1.355

9.  Postchallenge administration of brincidofovir protects healthy and immune-deficient mice reconstituted with limited numbers of T cells from lethal challenge with IHD-J-Luc vaccinia virus.

Authors:  Marina Zaitseva; Kevin Tyler McCullough; Stephanie Cruz; Antonia Thomas; Claudia G Diaz; Laurie Keilholz; Irma M Grossi; Lawrence C Trost; Hana Golding
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

10.  VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone.

Authors:  Leonard Moise; R Mark Buller; Jill Schriewer; Jinhee Lee; Sharon E Frey; David B Weiner; William Martin; Anne S De Groot
Journal:  Vaccine       Date:  2010-11-04       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.